Theseus Pharmaceuticals
Latest round
- Series B
Last raised
- Jan 2021
Total raised
- $95M
Investors
- 11
About Theseus Pharmaceuticals
, is a biotechnology company designed to develop pan-variant kinase inhibitors. Victor Rivera, David Dalgarno, Wei-Sheng Huang, and William Shakesphere are the co-founders, and Tim Clackson is the President and CEO of the company as of 2021. In April 2021, Theseus Pharmaceuticals, Inc. In October 2021, the firm became a publicly listed company on the Nasdaq under the ticker symbol THRX., a portfolio company of Cressey & Company, Welsh, Carson, Anderson & Stowe, Select Medical Corporation. The company focuses on the research and development of medicines designed to predict and block treatment-resistant cancer mutations, as well as the treatment of refractory GIST, helping the healthcare industry to address cancer resistance concerns. THE-630, a next-generation pan-variant KIT inhibitor under research by Theseus Pharmaceuticals for the treatment of refractory GIST, is a next-generation pan-variant KIT inhibitor in development. Theseus' pipeline also provides a targeted EGFR inhibitor to treat patients with non-small cell lung cancer who have C797S-mediated resistance to osimertinib in the first or second line. Theseus is developing tyrosine kinase inhibitors (TKIs) for targeted therapies that address all major drug resistance mutations and a fourth-generation, selective epidermal growth factor receptor (EGFR) inhibitor for C797S-mediated resistance to first- or second-line osimertinib treatment in patients with non-small cell lung cancer (NSCLC).
Who invested in Theseus Pharmaceuticals
11 investors across 1 round
See all investors in Theseus Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series B
Jan 22, 2021
Amount
$95M
Investors
Questions about Theseus Pharmaceuticals
Who invested in Theseus Pharmaceuticals?
Theseus Pharmaceuticals has 11 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Theseus Pharmaceuticals raised?
Theseus Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Theseus Pharmaceuticals last raise money?
Theseus Pharmaceuticals's most recent round on record is a Series B, in Jan 2021.
What does Theseus Pharmaceuticals do?
, is a biotechnology company designed to develop pan-variant kinase inhibitors.
Where is Theseus Pharmaceuticals headquartered?
Theseus Pharmaceuticals is headquartered in Cambridge, US.
Which VCs invest in companies like Theseus Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Theseus Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Theseus Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.